American Orthopaedic Society for Sports Medicine Annual Meeting

American Orthopaedic Society for Sports Medicine Annual Meeting

Source:

Rothermich MA, et al. Long-term clinical outcomes of osteochondritis dissecans lesions of the capitellum treated with arthroscopy. Presented at: American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America Combined Meeting; July 7-11, 2021; Nashville, Tennessee.

Disclosures: Rothermich reports no relevant financial disclosures.
July 15, 2021
1 min read
Save

Arthroscopic treatment of osteochondritis dissecans has excellent long-term outcomes

Source:

Rothermich MA, et al. Long-term clinical outcomes of osteochondritis dissecans lesions of the capitellum treated with arthroscopy. Presented at: American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America Combined Meeting; July 7-11, 2021; Nashville, Tennessee.

Disclosures: Rothermich reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NASHVILLE, Tenn. — According to a presenter, elbow arthroscopy for patients with osteochondritis dissecans of the capitellum has excellent long-term outcomes and return to play rates.

At the American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America Combined Meeting, Marcus A. Rothermich, MD, an orthopedic surgeon at Andrews Sports Medicine and Orthopaedic Center, presented results from his single institution, retrospective study of 107 patients (average age of 15.2 years) treated with elbow arthroscopy for osteochondritis dissecans (OCD) of the capitellum from 2001 to 2018. Rothermich and colleagues used the American Shoulder and Elbow Surgeons – elbow (ASES-e), Andrews/Carson, American Sports Medicine Institute return to play and the Kerlan-Jobe Orthopaedic Clinic questionnaires to assess patient-reported outcomes (PROs).

After a mean follow-up of 8.3 years, patients who underwent arthroscopy for OCD had a mean ASES-e pain score of 4 out of 100, a function score of 34.5 out of 36 and a satisfaction score of 9.1 out of 10. Mean Andrews/Carson score was 87.1 out of 100.

Marcus A. Rothermich
Marcus A. Rothermich

Of the 90 patients with follow-up, 12% (n = 11) had revision surgery. Of the 87 patients who were athletes, 93% (n = 81) returned to their preoperative level of play. Baseball pitchers returned an average of 7.7 months, other throwing athletes returned an average of 7 months and non-throwing athletes returned an average of 5.4 months, Rothermich added.

“In conclusion, we found a 93% return to play rate with acceptable subjective long-term PRO scores and a 12% reoperation rate in this patient population,” Rothermich said. “Our hope is that knowledge of these long-term outcomes can be beneficial for future patients and also their medical providers.”